rheumatology immunomodulators (Pfizer Inc)
86
Structured Review
Pfizer Inc
rheumatology immunomodulators
Rheumatology Immunomodulators, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rheumatology+immunomodulators/immunomodulators+rheumatology/pmc13131211-203-23-36
Average 86 stars, based on 1 article reviews
Rheumatology Immunomodulators, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rheumatology+immunomodulators/immunomodulators+rheumatology/pmc13131211-203-23-36
Average 86 stars, based on 1 article reviews
rheumatology immunomodulators - by Bioz Stars,
2026-09
86/100 stars
Images
Related Articles
other:Article Title: Letter to the Editor Regarding “Evaluation of VTE, MACE, and Serious Infections Among Patients with RA Treated with Baricitinib Compared to TNFi: A Multi-Database Study of Patients in Routine Care Using Disease Registries and Claims Databases” Article Snippet: Johan Askling is the principal investigator for the ARTIS national safety monitoring of rheumatology immunomodulators which Karolina Institutet has entered into with Abbvie, BMS, Galapagos, Article Title: Incident rheumatoid arthritis and work loss: a nationwide sibling comparison study Article Snippet: Disclosure statement: J.A. has acted as principal investigator in agreements between Karolinska Institutet and the following entities, mainly for the safety monitoring of Article Title: Incidence of major adverse cardiovascular events in patients with rheumatoid arthritis treated with Janus kinase inhibitors compared to biologic disease-modifying antirheumatic drugs: data from an international collaboration of registries (the "JAK-pot" study). Article Snippet: See the T erm s and C onditions (https://onlinelibrary.w iley.com /term s-and-conditions) on W iley O nline L ibrary for rules of use; O A articles are governed by the applicable Article Title: Work loss in patients with rheumatoid arthritis treated with abatacept, rituximab, tocilizumab or TNF inhibitors: a nationwide direct drug-to-drug comparison. Article Snippet: J.A. has acted as principal investigator in agreements between Karolinska Institutet and the following entities, mainly for the safety monitoring of |